Paris
France
31
2024-11-14
The entities that hold a legal rights for patent applications filed by inventor Klatzmann David:
David Klatzmann from Paris, FR has applied for patents for these inventions. The list has both pending applications and granted patents:
INTERLEUKIN 2 CHIMERIC CONSTRUCTS WITH TARGETING SPECIFICY TO INFLAMED TISSUES
#2 | 2024-11-07VIRAL-LIKE PARTICLES FOR THE TREATMENT OR PREVENTION OF AN INFECTION BY A CORONAVIRIDAE VIRUS
#3 | 2023-05-18LOW DOSE IL-2 FOR TREATING AUTOIMMUNE-RELATED OR INFLAMMATORY DISORDERS
#4 | 2023-02-02INTERLEUKIN 2 CHIMERIC CONSTRUCTS
#5 | 2021-09-30VIRUS-LIKE PARTICLES WHICH CAN BE USED IN THE TREATMENT OF ALLERGIES
#6 | 2021-08-05COMBINATION OF INTERLEUKIN-2 WITH AN INTERLEUKIN 1 INHIBITOR, CONJUGATES AND THERAPEUTIC USES THEREOF
#7 | 2021-04-29Use of interleukin 2 for treating Sjögren's syndrome
#8 | 2021-02-11Use of low dose IL-2 for treating autoimmune-related or inflammatory disorders
#9 | 2020-11-05Virus-like particles which can be used in the treatment of autoimmune diseases
#10 | 2019-11-21Use of low dose IL-2 for treating autoimmune—related or inflammatory disorders
#11 | 2019-05-23Genetically modified T lymphocytes
#12 | 2019-02-28USE OF INTERLEUKIN 2 FOR TREATING SPONDYLOARTHRITIS
#13 | 2018-08-16PROTOZOAN VARIANT-SPECIFIC SURFACE PROTEINS (VSP) AS CARRIERS FOR ORAL DRUG DELIVERY
#14 | 2017-12-07Compositions and methods for treatment of cytomegalovirus
#15 | 2017-10-26Use of low dose IL-2 for treating autoimmune related or inflammatory disorders
#16 | 2017-01-26Interleukin-2 for treating food allergy
#17 | 2015-06-11Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery
#18 | 2014-09-11Synthetic viruses and uses thereof
#19 | 2014-08-21METHOD FOR DETERMINING A PREDICTIVE FUNCTION FOR DISCRIMINATING PATIENTS ACCORDING TO THEIR DISEASE ACTIVITY STATUS
#20 | 2014-03-18Synthetic viruses and uses thereof
#21 | 2014-01-09Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery
#22 | 2014-01-02Method for stimulating T lymphocytes with IL-2
#23 | 2013-04-18Pharmaceutical compositions comprising a polypeptide comprising at least one CXXC motif and heterologous antigens and uses thereof
#24 | 2010-09-16METHOD FOR OPTIMIZING BLOOD CELL TRANSPLANTS
#25 | 2010-08-26TREATMENT OF TUMORS USING T LYMPHOCYTE PREPARATIONS
#26 | 2008-08-28Treating immunodeficiencies by intrathymic injection of nucleotide sequences
#27 | 2007-06-07Methods for the identification and preparation of regulator/suppressor t lymphocytes, compositions and use thereof
#28 | 2007-01-18α-β C4BP-type recombinant heteromultimeric proteins
#29 | 2006-07-11α-β C4BP-type recombinant heteromultimeric proteins
#30 | 2005-03-29Highly productive packaging lines
#31 | 2005-03-03Albumin derivatives with therapeutic functions
595598 ⎘